Publikationen (63) Publikationen, an denen Forscher/innen teilgenommen haben

2021

  1. A Web-based Application for Spirometry Quality in a Public Health System. 10 Year Follow Up

    Archivos de Bronconeumologia, Vol. 57, Núm. 11, pp. 724-725

  2. Aspiration Risk Factors, Microbiology, and Empiric Antibiotics for Patients Hospitalized With Community-Acquired Pneumonia

    Chest, Vol. 159, Núm. 1, pp. 58-72

  3. Association of the CFTR gene with asthma and airway mucus hypersecretion

    PLoS ONE, Vol. 16, Núm. 6 June

  4. Bleeding risk in hospitalized patients with COVID-19 receiving intermediate- or therapeutic doses of thromboprophylaxis

    Journal of Thrombosis and Haemostasis, Vol. 19, Núm. 8, pp. 1981-1989

  5. Carmustine Pulmonary Toxicity: A Diagnosis to Bear in Mind Even in Times of COVID

    Archivos de Bronconeumologia, Vol. 57, pp. 52-54

  6. Cell-selective altered cargo properties of extracellular vesicles following in vitro exposures to intermittent hypoxia

    International Journal of Molecular Sciences, Vol. 22, Núm. 11

  7. Ceramide metabolism and parkinson’s disease—therapeutic targets

    Biomolecules, Vol. 11, Núm. 7

  8. Ceramide metabolism enzymes—therapeutic targets against cancer

    Medicina (Lithuania), Vol. 57, Núm. 7

  9. Clinical characteristics and 3-month outcomes in cancer patients with incidental versus clinically suspected and confirmed pulmonary embolism

    European Respiratory Journal, Vol. 58, Núm. 1

  10. Clinical characteristics of SARS-CoV-2 infection in children with cystic fibrosis: An international observational study

    Journal of Cystic Fibrosis, Vol. 20, Núm. 1, pp. 25-30

  11. Comparative clinical prognosis of massive and non-massive pulmonary embolism: A registry-based cohort study

    Journal of Thrombosis and Haemostasis, Vol. 19, Núm. 2, pp. 408-416

  12. Concordancia interobservador de la ecocardiografía transtorácica en el seguimiento de la embolia pulmonar

    Revista española de patología torácica, Vol. 33, Núm. 4, pp. 235-237

  13. Cost-Utility Analysis of a Dolutegravir-Based Versus Low-Dose Efavirenz-Based Regimen for the Initial Treatment of HIV-Infected Patients in Cameroon (NAMSAL ANRS 12313 Trial)

    PharmacoEconomics, Vol. 39, Núm. 3, pp. 331-343

  14. Cytologic Contamination of the Sampling Needle in Endobronchial Ultrasound

    Archivos de Bronconeumologia

  15. Diagnostic delay of associated interstitial lung disease increases mortality in rheumatoid arthritis

    Scientific Reports, Vol. 11, Núm. 1

  16. Discordance in treatment of chronic obstructive pulmonary disease following GesEPOC Guideline vs. GOLD

    Revista Clinica Espanola, Vol. 221, Núm. 9, pp. 536-539

  17. Effect of a Pulmonary Embolism Diagnostic Strategy on Clinical Outcomes in Patients Hospitalized for COPD Exacerbation: A Randomized Clinical Trial

    JAMA - Journal of the American Medical Association, Vol. 326, Núm. 13, pp. 1277-1285

  18. En España apenas llegamos al 1% del tratamiento dental de la apnea del sueño, en Europa es el 30%

    Maxillaris: Actualidad profesional e industrial del sector dental, Año 23, Núm. 256, pp. 32-37

  19. Factors for severe outcomes following SARS-CoV-2 infection in people with cystic fibrosis in Europe

    ERJ Open Research, Vol. 7, Núm. 4

  20. Forum COPD Working Group Consensus on the Diagnosis, Treatment and Follow-Up of COPD

    Archivos de Bronconeumologia, Vol. 57, Núm. 9, pp. 596-599